Voloridge Investment Management
HUMA icon

Voloridge Investment Management’s Humacyte HUMA Stock Holding History

Voloridge Investment Management’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-499,202
Closed -$2.52M – 1258
2024
Q4 		$2.52M Sell
499,202
-760,738
-60% -$3.76M 0.01% 917
2024
Q3 		$6.85M Buy
1,259,940
+572,644
+83% +$3.78M 0.02% 699
2024
Q2 		$3.3M Buy
+687,296
New +$3.58M 0.01% 856

Other funds holding HUMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return

Voloridge Investment Management's HUMA Position: Q1 2025 in Review

Voloridge Investment Management sold out of Humacyte (HUMA) in Q1 2025, closing a stake of 499,202 shares — an estimated $2.52M sold.

Voloridge Investment Management first reported a position in HUMA in Q2 2024 and held it in 3 quarters. The position peaked at $6.85M in Q3 2024. 168 funds tracked by Wall St. Rank hold HUMA as of Q1 2025.

  • Voloridge Investment Management reported no remaining Humacyte position as of Q1 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 499,202 Humacyte shares in Q1 2025, an estimated $2.52M.
  • Voloridge Investment Management first reported a position in Humacyte in Q2 2024 and held it in 3 quarters.
  • Voloridge Investment Management's Humacyte position peaked at $6.85M in Q3 2024.
  • 168 funds tracked by Wall St. Rank held Humacyte as of Q1 2025.

Based on Voloridge Investment Management's 13F filing for Q1 2025, filed 15 May 2025.